Go Pro

Insider Selling: Proto Labs (NYSE:PRLB) CFO Sells 4,900 Shares of Stock

Proto Labs logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Proto Labs CFO Daniel Schumacher sold 4,900 shares for approximately $417,529 at an average price of $85.21, reducing his ownership by 10.91%. The transaction was made under a pre-arranged Rule 10b5-1 trading plan.
  • Proto Labs shares rose to $87.47, with the stock trading near its 12-month high of $93.00. The company recently exceeded quarterly earnings and revenue expectations, reporting $0.60 EPS and $149.34 million in revenue.
  • Analysts maintain a generally positive outlook, with a consensus “Buy” rating and an average price target of $89.00; institutional investors own approximately 84.54% of the company.
  • MarketBeat previews the top five stocks to own by October 1st.

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) CFO Daniel Schumacher sold 4,900 shares of the stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $85.21, for a total value of $417,529.00. Following the sale, the chief financial officer owned 40,019 shares of the company's stock, valued at approximately $3,410,018.99. This represents a 10.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Schumacher also recently made the following trade(s):

  • On Wednesday, September 16th, Daniel Schumacher sold 100 shares of Proto Labs stock. The stock was sold at an average price of $85.00, for a total value of $8,500.00.

Proto Labs Stock Performance

Shares of Proto Labs stock traded up $1.05 during trading on Friday, hitting $87.47. 453,613 shares of the stock traded hands, compared to its average volume of 196,226. The stock has a market cap of $2.09 billion, a P/E ratio of 69.98 and a beta of 1.42. Proto Labs, Inc. has a twelve month low of $45.10 and a twelve month high of $93.00. The company has a fifty day moving average price of $81.14 and a two-hundred day moving average price of $72.55.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business had revenue of $149.34 million during the quarter, compared to analyst estimates of $144.53 million. During the same quarter in the previous year, the business earned $0.41 EPS. Proto Labs's quarterly revenue was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, equities research analysts expect that Proto Labs, Inc. will post 1.46 EPS for the current fiscal year.

Analyst Ratings Changes

PRLB has been the topic of several analyst reports. Weiss Ratings upgraded Proto Labs from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, September 3rd. Zacks Research raised Proto Labs from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 6th. Benchmark upped their price target on Proto Labs from $70.00 to $91.00 and gave the company a "buy" rating in a research report on Thursday, July 2nd. Wall Street Zen lowered Proto Labs from a "strong-buy" rating to a "buy" rating in a research note on Saturday, July 18th. Finally, Needham & Company LLC upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a research note on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $89.00.

Read Our Latest Stock Analysis on PRLB

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of PRLB. Engineers Gate Manager LP boosted its holdings in shares of Proto Labs by 84.7% in the 2nd quarter. Engineers Gate Manager LP now owns 26,780 shares of the industrial products company's stock worth $2,183,000 after acquiring an additional 12,280 shares in the last quarter. Corient Private Wealth LP increased its holdings in Proto Labs by 16.1% during the 2nd quarter. Corient Private Wealth LP now owns 12,427 shares of the industrial products company's stock valued at $1,013,000 after purchasing an additional 1,723 shares in the last quarter. Angeles Wealth Management LLC increased its holdings in Proto Labs by 12.4% during the 2nd quarter. Angeles Wealth Management LLC now owns 5,045 shares of the industrial products company's stock valued at $411,000 after purchasing an additional 555 shares in the last quarter. Turner Financial Group Inc. bought a new position in Proto Labs in the 2nd quarter valued at $395,000. Finally, Susquehanna Fundamental Investments LLC raised its position in Proto Labs by 227.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 33,760 shares of the industrial products company's stock valued at $2,752,000 after purchasing an additional 23,435 shares during the last quarter. Institutional investors own 84.54% of the company's stock.

Proto Labs Company Profile

(Get Free Report)

Proto Labs, Inc NYSE: PRLB, doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.

The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.

Further Reading

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines